Le Lézard
Classified in: Oil industry, Business
Subject: INO

Frost & Sullivan Publishes Annual Update on Energix Renewable Energies. Entering the US market is a significant long-term growth opportunity; major project and regulatory milestones in Poland and Israel increase installed capacity; new in-house O&M and project management capabilities improve financial and operational efficiency; target price raised to NIS 4.05.


TEL AVIV, Israel, May 16, 2018 /CNW/ -- The TASE analysis project was launched in 2016 in order to raise investors' awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of investors from Israel and abroad. Its goal is to encourage investments in these companies by improving understanding of these industries and companies in the market.

In order to maintain professional, independent and unbiased analysis, the companies signed an agreement with the TASE to receive the analysis services for an obligatory period of two years. The companies cannot withdraw from the project during this period. The analysis is funded by the companies surveyed with funding from the Chief Scientist and the TASE.

Summary of Highlights

Energix released its annual report on 12 March, 2018 detailing the following:

The company operates in a highly regulated market, with growth dependent upon political sentiment towards renewables, the availability of financing and interest rates.

We increase Energix's equity value to $425.2M / NIS 1,526.49M corresponding to a target price ranging between NIS 3.85 a NIS 4.29; a mean of NIS 4.05.

About the Company - Energix Renewable Energies Ltd. (hereinafter "Energix" or "the Company") is a renewable energy company, currently active in the field of Solar Photovoltaic (PV) and Wind Energies. As one of the largest Israeli Independent Power Producers (IPPs), the company initiates, develops, constructs and owns long-term renewable energy projects. Once it has secured production rights through government tenders, Energix sells the generated electricity to utility companies who distribute electricity to end users. Energix shares have traded on the Tel Aviv Stock Exchange since 2011.

Read the full report here.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us:  Start the discussion

Contact:

Kristi Cekani 
Corporate Communications - Frost & Sullivan, Europe
P: +39.02.4851.6133
E: [email protected]
http://www.frost.com

 

 

SOURCE Frost & Sullivan


These press releases may also interest you

at 08:15
YETI Holdings, Inc. ("YETI") today announced that it plans to report its first quarter fiscal year 2024 financial results on Thursday, May 9, 2024, before the market opens. YETI will host a conference call at 8:00 a.m. ET to discuss its financial...

at 08:15
AdaptHealth Corp. ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial...

at 08:15
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended...

at 08:15
GE Vernova Inc. is scheduled to announce its first quarter 2024 financial results on Thursday, April 25, 2024, before market open. The company will host a webcast to discuss its financial results at 7:30 AM ET, which can be accessed at...

at 08:11
With the fourth block reward halving around the corner for BTC and BSV, there will be increased focus from miners regarding the scaling potential of blockchain technology, with a focus on revenue, cost efficiencies, and sustainability....

at 08:10
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Management...



News published on and distributed by: